Abstract: The present invention relates to an apparatus for determining a cell culturing condition and a method of operating the same. The method includes acquiring a first quality attribute and a first influence variable at a first point in time from a cell culture medium, acquiring a first injection variable, applying at least one of the first quality attribute, the first influence variable, and the first injection variable to a culture simulation model and acquiring a second quality attribute and a second influence variable at a second point in time, and selectively changing the first injection variables so that the second quality attribute meets a predetermined condition.

Abstract: Provided are a fructose-4-epimerase variant having tagatose conversion activity, and a method of preparing tagatose using the same.

Abstract: Proposed is a method of monitoring odor-causing substances in flue gas, which comprises: providing a flue gas containing one or more odor-causing substances; introducing the flue gas into an odor removal unit; producing a gas-phase stream; dissolving a portion of the gas-phase stream in a solvent to produce a liquid-phase stream; and measuring an absorbance of the liquid-phase stream to identify the odor-causing substances.

Abstract: The present invention relates to new antibody-drug conjugates (ADCs) targeting ROR1, active metabolites of such ADCs, methods for preparation of such ADCs, uses for such ADCs in treatment and/or prevention of illnesses, and uses for such ADCs in production of drugs for treatment and/or prevention of diseases, more specifically diseases associated with over-expression of ROR1, for example cancer. More specifically, the present invention relates to an antibody-drug conjugate comprising an antibody that binds to ROR1 or an antigen-binding fragment thereof, and a pharmaceutical composition comprising the same.

Abstract: Provided are a composition for producing tagatose, comprising fructose-6-phosphate 4-epimerase, and a method of producing tagatose using the same.

Abstract: Provided are a tagatose-bisphosphate aldolase variant having tagatose conversion activity, and a method of preparing tagatose using the same.

Abstract: The present invention relates to new antibody-drug conjugates (ADCs) targeting ROR1, active metabolites of such ADCs, methods for preparation of such ADCs, uses for such ADCs in treatment and/or prevention of illnesses, and uses for such ADCs in production of drugs for treatment and/or prevention of diseases, more specifically diseases associated with over-expression of ROR1, for example cancer. More specifically, the present invention relates to an antibody-drug conjugate comprising an antibody that binds to ROR1 or an antigen-binding fragment thereof, and a pharmaceutical composition comprising the same.

Abstract: The present invention relates to a method of reducing carbon dioxide and air pollutants, and more particularly to a method of simultaneously reducing emissions of carbon dioxide and air pollutants, in which an off-gas containing carbon dioxide, SOx, and NOx is passed through a sulfur-oxidizing microorganism reactor, thereby converting carbon dioxide present in the off-gas into biomass, SOx into sulfate ions, and NOx into amino-N.

Abstract: The present disclosure relates to a composition for producing tagatose, comprising fructose-6-phosphate-4-epimerase, and a method of producing tagatose using the same.

Abstract: Provided are a hexuronate C4-epimerase variant with improved activity in converting D-fructose by D-tagatose of hexuronate C4-epimerase and a method for production of D-tagatose using them.

Abstract: Provided are a fructose-4-epimerase variant having tagatose conversion activity, and a method of producing tagatose using the same.

Abstract: The present invention relates to a method of reducing carbon dioxide and air pollutants, and more particularly to a method of simultaneously reducing emissions of carbon dioxide and air pollutants, in which an off-gas containing carbon dioxide, SOx, and NOx is passed through a sulfur-oxidizing microorganism reactor, thereby converting carbon dioxide present in the off-gas into biomass, SOx into sulfate ions, and NOx into amino-N.

Abstract: Provided are a composition for producing tagatose, comprising fructose-6-phosphate 4-epimerase, and a method of producing tagatose using the same.

Abstract: Provided are a hexuronate C4-epimerase variant with improved activity in converting D-fructose by D-tagatose of hexuronate C4-epimerase and a method for production of D-tagatose using them.

Abstract: Provided is a heat pump system including a compressor for compressing a refrigerant the heat pump system including: an input interface configured to receive an input of an authentication code; a display configured to display the authentication code input through the input interface; and a controller to control an operation of the heat pump system according to whether a control program to control the operation is to be activated based on the authentication code input through the input interface.

Abstract: The present invention relates to a novel thermophilic and thermoresistant polyphosphate-dependent glucokinase having excellent stability, a composition comprising the same, and a method for producing glucose 6-phosphate using the same.

Abstract: The present application relates to a psicose-6-phosphate phosphatase, a microorganism comprising the same, and a method for producing psicose using the same.

Abstract: Provided are a fructose-4-epimerase variant having tagatose conversion activity, and a method of producing tagatose using the same.

Abstract: Provided are a fructose-4-epimerase variant having tagatose conversion activity, and a method of preparing tagatose using the same.

Abstract: Provided are a tagatose-bisphosphate aldolase variant having tagatose conversion activity, and a method of preparing tagatose using the same.